KESTRA MEDICAL TECHNOLOGIES LTD

KMTS | Healthcare | NASDAQ
$26.53
-0.12 (-0.46%)

Key Metrics

Market Cap
$1.36B
P/E Ratio
-10.53
EPS
$-2.52
Beta
N/A
Dividend Yield
N/A
ROE
289.25%
Current Ratio
6.84

Company Information

Industry
Medical Instruments Supplies

About KESTRA MEDICAL TECHNOLOGIES LTD

Kestra Medical Technologies Ltd operates as a wearable medical device and digital healthcare company It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive intelligent and connected The company develops and commercializes Cardiac Recovery System platform a system that integrates monitoring therapeutic treatment digital health and patient support services into a single unified solution Its Cardiac Recovery System platform is the ASSURE WCD a wearable cardioverter defibrillator WCD used to protect patients at an elevated risk of sudden cardiac arrest SCA The companys Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes The company was founded in 2014 and is based in Kirkland Washington

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-09-11 $-0.46 $-0.66 +-30.3%

Financial Ratios (TTM)

Gross Margin
44.55%
Operating Margin
-188.98%
Net Margin
-192.26%
ROA
-37.32%
Price to Book
7.42
Price to Sales
26.52